Literature DB >> 12004023

Brief exposure to high-dose transforming growth factor-beta1 enhances periosteal chondrogenesis in vitro: a preliminary report.

Yasushi Miura1, Javad Parvizi, James S Fitzsimmons, Shawn W O'Driscoll.   

Abstract

BACKGROUND: Articular cartilage has limited potential for repair. There have been various attempts aimed at improving the repair process in articular cartilage. Transforming growth factor-beta1 (TGF-beta1) has a stimulatory effect on chondrogenesis in periosteal explants. The purpose of the present study was to determine the effect of brief exposures (i.e., thirty and sixty minutes) of high concentrations of TGF-beta1 on periosteal chondrogenesis.
METHODS: Five hundred and seventy-three periosteal explants were harvested from forty-six two-month-old male New Zealand White rabbits. Explants were exposed to 50 or 100 ng/mL of TGF-beta1 for thirty or sixty minutes. The amount of cartilage formed was then determined with use of a standardized six-week agarose culture assay.
RESULTS: There was a significant increase in the amount of cartilage formation (p < 0.01), Type-II collagen content (p < 0.05), and sulfate incorporation (p < 0.0001) in explants treated with TGF-beta1. Maximal stimulation occurred following exposure to 100 ng/mL of TGF-beta1 for thirty minutes. There was also an increase in chondrocyte proliferation as measured by [ (3) H-] thymidine incorporation on day 5 of culture (p < 0.049).
CONCLUSIONS: The findings of this study indicate that exposure to TGF-beta1 has a stimulatory effect on periosteal chondrogenesis. This stimulatory effect is observed even with a very brief exposure time of thirty minutes. CLINICAL RELEVANCE: A possible clinical application of these findings is exposure of periosteal grafts that are currently utilized clinically to resurface articular defects to TGF-beta1 during the short time between graft procurement and implantation into the joint. This may obviate the need for intra-articular administration of TGF-beta1 and may enhance the ultimate graft incorporation and quality of cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004023     DOI: 10.2106/00004623-200205000-00015

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  10 in total

Review 1.  The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring.

Authors:  Richard L Chalmers
Journal:  Int Wound J       Date:  2011-03-30       Impact factor: 3.315

2.  Directional fluid flow enhances in vitro periosteal tissue growth and chondrogenesis on poly-epsilon-caprolactone scaffolds.

Authors:  Yih-Wen Tarng; Michelle E Casper; James S Fitzsimmons; James J Stone; Joris Bekkers; Kai-Nan An; Fong-Chin Su; Shawn W O'Driscoll; Gregory G Reinholz
Journal:  J Biomed Mater Res A       Date:  2010-10       Impact factor: 4.396

3.  Molecular characterization of spontaneous and growth-factor-augmented chondrogenesis in periosteum-bone tissue transferred into a joint.

Authors:  Martin Jung; Tobias Gotterbarm; Annette Gruettgen; Simona Berardi Vilei; Steffen Breusch; Wiltrud Richter
Journal:  Histochem Cell Biol       Date:  2005-06-01       Impact factor: 4.304

4.  Temporal exposure to chondrogenic factors modulates human mesenchymal stem cell chondrogenesis in hydrogels.

Authors:  Amanda N Buxton; Chelsea S Bahney; Jung U Yoo; Brian Johnstone
Journal:  Tissue Eng Part A       Date:  2010-10-25       Impact factor: 3.845

5.  No effect of subperiosteal growth factor application on periosteal neo-chondrogenesis in osteoperiosteal bone grafts for osteochondral defect repair.

Authors:  Tobias Gotterbarm; Steffen J Breusch; Simona Berardi Vilei; Pierre Mainil-Varlet; Wiltrud Richter; Martin Jung
Journal:  Int Orthop       Date:  2013-03-17       Impact factor: 3.075

6.  Rejuvenation of periosteal chondrogenesis using local growth factor injection.

Authors:  G G Reinholz; J S Fitzsimmons; M E Casper; T J Ruesink; H W Chung; J C Schagemann; S W O'Driscoll
Journal:  Osteoarthritis Cartilage       Date:  2008-11-06       Impact factor: 6.576

7.  Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair.

Authors:  Rosa Chung; Bruce K Foster; Cory J Xian
Journal:  Stem Cells Int       Date:  2011-07-26       Impact factor: 5.443

8.  Early Addition of Parathyroid Hormone-Related Peptide Regulates the Hypertrophic Differentiation of Mesenchymal Stem Cells.

Authors:  Karthikeyan Rajagopal; Sowmya Ramesh; Vrisha Madhuri
Journal:  Cartilage       Date:  2020-01-02       Impact factor: 3.117

9.  Allogeneic and autogenous transplantations of MSCs in treatment of the physeal bone bridge in rabbits.

Authors:  Ladislav Planka; Petr Gal; Helga Kecova; Jiri Klima; Jana Hlucilova; Eva Filova; Evzen Amler; Petr Krupa; Leos Kren; Robert Srnec; Lucie Urbanova; Jana Lorenzova; Alois Necas
Journal:  BMC Biotechnol       Date:  2008-09-12       Impact factor: 2.563

10.  Extracellular Matrix (ECM) Multilayer Membrane as a Sustained Releasing Growth Factor Delivery System for rhTGF-β3 in Articular Cartilage Repair.

Authors:  Soon Sim Yang; Long Hao Jin; Sang-Hyug Park; Moon Suk Kim; Young Jick Kim; Byung Hyune Choi; Chun Tek Lee; So Ra Park; Byoung-Hyun Min
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.